Sun Pharmaceutical Industries Limited

This study tests a drug called tildrakizumab in children aged 6 to 17 with moderate-to-severe plaque psoriasis. The goal is to see if it safely reduces skin symptoms like redness and scaling. Participants receive the drug or a placebo, and researchers monitor results over time. S…

This study looks at the long-term safety and effectiveness of tildrakizumab in people with psoriatic arthritis, a condition causing joint pain and skin problems. About 529 participants who completed an earlier study will receive the drug openly and be monitored for side effects a…

This study tests a drug called tildrakizumab against a placebo in 296 adults with active psoriatic arthritis who have never taken anti-TNF medications. The goal is to see if tildrakizumab reduces joint pain and swelling by at least 20%. Participants must have had psoriatic arthri…

This study tests a medication called tildrakizumab, given as a shot under the skin, for people with moderate to severe genital psoriasis. About 206 adults will receive either the drug or a placebo to see if it clears the rash and reduces itching. The goal is to improve symptoms a…

This study looks at how a prescription acne cream (clascoterone 1%) changes the size of oil glands and the makeup of skin oil in people with moderate acne. Ten adults aged 18-35 with oily skin and prominent pores will use the cream for 3 months. Small skin samples and oil tests w…